ix biopharma

Company in the news

iX Biopharma enters China market with licensing agreement for erectile dysfunction drug

SINGAPORE (Apr 27): iX Biopharma has entered into a 10-year licensing agreement with Yiling Pharmaceutical in China for the licensing, supply, and distribution of Wafesil, a fast-dissolvi

Broker's Calls

IHH Healthcare to see an exciting 2019 with increasingly palatable valuations: UOB

SINGAPORE (May 31): UOB Kay Hian is maintaining “buy” on IHH Healthcare with a target price of RM6.30 ($2.07), which implies 32.8 times 2020F P/E – well below its historical five-year 12 month forw

In print this week

This local start-up is using soft robotics to help rehabilitate the hands

SINGAPORE (Mar 22): Roceso Technologies designs and manufactures robotic gloves that are used to help stroke or spinal cord injury patients regain function in their hands through neurological and m

Joint ventures and alliances

Biolidics partners Japan's Sysmex Corp for cancer-related R&D

SINGAPORE (Feb 20): Biolidics Limited has established a strategic partnership with Sysmex Corporation, a Tokyo Stock Exchange-listed supplier of hematology instruments, to collaborate on the develo

In print this week

How immersive technology could drive the future of healthcare

SINGAPORE (Jan 11): Immersive technology is ­increasingly being deployed in various fields other than electronic games and entertainment. 


Success favours the well-groomed

SINGAPORE (Dec 3): There is a subtle but pervasive trend you might not have noticed: The majority of power players, visionaries and CEOs featured in the media tend to be immaculately groomed.

Special Feature

Tested and proven

SINGAPORE (Nov 5): It is not uncommon to chance upon giant billboards, TV and radio commercials and sponsored events with hair treatment clinics promising a lustrous head of hair,


Cennerv lodges prelim offer documents for Catalist listing, to acquire US subsidiary with proceeds

SINGAPORE (Sept 21): Cennerv Pharmaceuticals on Wednesday lodged its preliminary prospectus ahead of its planned initial public offering (IPO) on the SGX Catalist board.

Startups • Entrepreneurs • Digital economy

Enterprise Singapore and Bpifrance call for proposals on joint France-Singapore innovation projects

SINGAPORE (Sept 18): Enterprise Singapore and Bpifrance are calling for proposals on joint innovation projects in technological and application areas including advanced manufacturing, clean technol


Clearbridge BioMedics receives $6.6 mil in pre-IPO funding ahead of targeted 4Q launch

SINGAPORE (June 28): Clearbridge BioMedics has announced $6.6 million in pre-initial public offering (IPO) funding from oncology medical professionals, as well as investors focused in healthcare &a

Be informed of the stories that matter